First Mercantile Trust’s BioMarin Pharmaceuticals BMRN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2021
Q3
$243K Sell
3,145
-249
-7% -$19.2K 0.03% 342
2021
Q2
$283K Sell
3,394
-293
-8% -$24.4K 0.03% 305
2021
Q1
$278K Buy
3,687
+1,027
+39% +$77.4K 0.03% 318
2020
Q4
$233K Sell
2,660
-380
-13% -$33.3K 0.03% 366
2020
Q3
$228K Sell
3,040
-4,363
-59% -$327K 0.03% 366
2020
Q2
$913K Buy
7,403
+54
+0.7% +$6.66K 0.11% 106
2020
Q1
$621K Buy
7,349
+92
+1% +$7.77K 0.09% 130
2019
Q4
$614K Sell
7,257
-141
-2% -$11.9K 0.07% 179
2019
Q3
$499K Sell
7,398
-718
-9% -$48.4K 0.05% 240
2019
Q2
$695K Buy
8,116
+206
+3% +$17.6K 0.07% 150
2019
Q1
$703K Sell
7,910
-1,799
-19% -$160K 0.17% 145
2018
Q4
$826K Buy
9,709
+1,696
+21% +$144K 0.2% 120
2018
Q3
$777K Buy
8,013
+99
+1% +$9.6K 0.15% 155
2018
Q2
$745K Buy
7,914
+1,553
+24% +$146K 0.15% 159
2018
Q1
$516K Buy
6,361
+89
+1% +$7.22K 0.11% 242
2017
Q4
$559K Sell
6,272
-596
-9% -$53.1K 0.11% 231
2017
Q3
$639K Sell
6,868
-253
-4% -$23.5K 0.12% 226
2017
Q2
$647K Sell
7,121
-1,908
-21% -$173K 0.12% 217
2017
Q1
$793K Sell
9,029
-830
-8% -$72.9K 0.12% 199
2016
Q4
$817K Buy
9,859
+2,459
+33% +$204K 0.13% 197
2016
Q3
$685K Sell
7,400
-1,550
-17% -$143K 0.09% 301
2016
Q2
$696K Hold
8,950
0.09% 319
2016
Q1
$738K Sell
8,950
-2,120
-19% -$175K 0.09% 287
2015
Q4
$1.16M Buy
11,070
+700
+7% +$73.4K 0.12% 212
2015
Q3
$1.09M Buy
10,370
+83
+0.8% +$8.74K 0.11% 245
2015
Q2
$1.41M Buy
10,287
+900
+10% +$123K 0.12% 208
2015
Q1
$1.17M Buy
9,387
+7,943
+550% +$989K 0.1% 274
2014
Q4
$131K Sell
1,444
-131
-8% -$11.9K 0.01% 773
2014
Q3
$114K Buy
1,575
+65
+4% +$4.71K 0.01% 846
2014
Q2
$94K Hold
1,510
0.01% 829
2014
Q1
$103K Sell
1,510
-300
-17% -$20.5K 0.01% 906
2013
Q4
$127K Hold
1,810
0.01% 812
2013
Q3
$131K Sell
1,810
-600
-25% -$43.4K 0.01% 809
2013
Q2
$134K Buy
+2,410
New +$134K 0.01% 834